SciTransfer
Organization

NACIONALINIS MAISTO IR VETERINARIJOS RIZIKOS VERTINIMO INSTITUTAS

Lithuania's national food and veterinary risk assessment authority, specializing in zoonotic disease surveillance, African Swine Fever, and foodborne pathogen epidemiology.

Research institutefoodLTThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€26K
Unique partners
63
What they do

Their core work

Lithuania's national authority for food and veterinary risk assessment, this public institute evaluates biological, chemical, and physical risks in food, feed, and the animal disease landscape. In practice, they monitor foodborne pathogens, coordinate disease surveillance programs, and translate veterinary risk data into national policy recommendations. In European research, they contribute as a national reference body — providing Lithuanian field data, epidemiological assessments, and regulatory expertise to pan-European consortia tackling zoonotic diseases and animal health emergencies. Their work sits at the intersection of laboratory science, surveillance systems, and public health policy.

Core expertise

What they specialise in

African Swine Fever surveillance and vaccine diagnosticsprimary
1 project

Participated in VACDIVA (2019-2024), a project developing a safe DIVA vaccine for ASF control and eradication, contributing epidemiological and diagnostic expertise.

One Health zoonotic disease surveillanceprimary
1 project

Participated in One Health EJP (2018-2023), a large European joint programme targeting foodborne zoonoses, antimicrobial resistance, and emerging threats across human-animal-environment interfaces.

Foodborne pathogen epidemiologysecondary
1 project

One Health EJP involvement covers foodborne pathogens, prevention programmes, and disease control with explicit epidemiology and microbiology scope.

Veterinary risk assessment for national policyprimary
2 projects

As a national risk assessment institute, both projects align directly with their statutory mission of translating research outputs into food safety and veterinary risk frameworks.

Evolution & trajectory

How they've shifted over time

Early focus
One Health zoonotic surveillance
Recent focus
African Swine Fever vaccine diagnostics

Their first H2020 engagement (2018) was deliberately broad — the One Health EJP placed them within a multi-hazard surveillance network covering foodborne zoonoses, parasitology, microbiology, and antimicrobial resistance. By 2019, they had narrowed sharply to one of the most politically urgent animal disease threats in the Baltic region: African Swine Fever. The shift from broad disease monitoring to a specific vaccine development and DIVA diagnostics project suggests they moved from surveillance generalist toward specialist contributor in a crisis-driven research area where Lithuania has acute national exposure along the wild boar migration corridor from Eastern Europe.

They appear to be deepening their specialization in African Swine Fever — a disease with growing urgency across EU member states — which makes them a natural partner for future ASF control, wildlife disease management, or veterinary diagnostics projects.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European24 countries collaborated

This institute exclusively joins projects as a participant, never as coordinator, which reflects the typical pattern of national regulatory bodies that contribute authoritative field data and surveillance infrastructure rather than driving research agendas. Both of their projects are large European consortia — One Health EJP in particular is one of the biggest food safety research programs in H2020 — meaning they are comfortable operating inside complex, multi-partner networks. Expect them to function as a specialist node: delivering Lithuanian national data, regulatory input, and diagnostic capacity rather than leading workpackages.

Despite only two projects, they have built connections with 63 unique partners across 24 countries — a direct consequence of participating in large European joint programmes like One Health EJP, which aggregates dozens of national institutes. Their network is genuinely pan-European with no visible geographic concentration beyond their Baltic base.

Why partner with them

What sets them apart

As Lithuania's national food and veterinary risk assessment body, they hold a statutory position that private research groups cannot replicate — official risk assessments, national surveillance data, and regulatory authority that gives any consortium credibility with EU food safety governance bodies. Their geographic position is also a research asset: Lithuania sits on the active ASF transmission corridor from Russia and Belarus into the EU, making their field epidemiology data on wild boar populations and domestic pig disease incidence directly relevant to any European disease control project. For a consortium building a project that needs a Baltic reference laboratory or official national competent authority, they are a precise fit.

Notable projects

Highlights from their portfolio

  • VACDIVA
    The highest-funded project for this institute and one of the most strategically urgent in European animal health — developing a DIVA-compatible ASF vaccine, a problem unsolved for decades with major consequences for EU livestock industries.
  • One Health EJP
    Membership in this flagship European joint programme — one of H2020's largest coordinated food safety initiatives — signals that the institute is recognized as a national reference body within EU disease surveillance infrastructure.
Cross-sector capabilities
Public health — zoonotic diseases bridge animal and human epidemiology, making their surveillance data relevant to human infectious disease researchWildlife and environmental management — ASF in wild boar populations connects to wildlife ecology and habitat management programmesAntimicrobial resistance — One Health EJP scope explicitly includes AMR, positioning them for health security and drug resistance research consortia
Analysis note: Profile is based on only 2 projects covering a short entry window (2018-2019). The institutional identity is clear from the organization name and project alignment, but research depth, specific laboratory capabilities, and true internal specialization cannot be confirmed from this data alone. The expertise evolution narrative is directionally valid but drawn from a very small sample. Confidence would rise significantly with 5+ projects.